New drugs in prostate cancer
The standard primary treatment for advanced prostate cancer has been hormonal therapy since the 1940s. However, prostate cancer inevitably progresses to castration-resistant prostate cancer (CRPC) after a median duration of 18 months of androgen deprivation therapy. In patients with CRPC, docetaxel...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2016-06-01
|
| Colección: | Prostate International |
| Materias: | |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S2287888216300216 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|